Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
MR/M012190/1
Medical Research Council - United Kingdom
16491
Cancer Research UK - United Kingdom
MR/N003284/1
Medical Research Council - United Kingdom
G1000143
Medical Research Council - United Kingdom
14136
Cancer Research UK - United Kingdom
G0401527
Medical Research Council - United Kingdom
16812
Cancer Research UK - United Kingdom
PubMed
28913878
DOI
10.1002/ijc.31047
Knihovny.cz E-zdroje
- Klíčová slova
- Chronic pancreatitis, association, genetic polymorphisms, pancreatic ductal adenocarcinoma,
- MeSH
- adenokarcinom genetika patologie MeSH
- chronická pankreatitida genetika patologie MeSH
- dospělí MeSH
- duktální karcinom slinivky břišní genetika patologie MeSH
- jaderné proteiny genetika MeSH
- jednonukleotidový polymorfismus * MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery genetika MeSH
- nádory slinivky břišní genetika patologie MeSH
- následné studie MeSH
- prognóza MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- trypsin genetika MeSH
- trypsinogen genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- jaderné proteiny MeSH
- MORC4 protein, human MeSH Prohlížeč
- nádorové biomarkery MeSH
- PRSS1 protein, human MeSH Prohlížeč
- PRSS2 protein, human MeSH Prohlížeč
- trypsin MeSH
- trypsinogen MeSH
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumor with a five-year survival of less than 6%. Chronic pancreatitis (CP), an inflammatory process in of the pancreas, is a strong risk factor for PDAC. Several genetic polymorphisms have been discovered as susceptibility loci for both CP and PDAC. Since CP and PDAC share a consistent number of epidemiologic risk factors, the aim of this study was to investigate whether specific CP risk loci also contribute to PDAC susceptibility. We selected five common SNPs (rs11988997, rs379742, rs10273639, rs2995271 and rs12688220) that were identified as susceptibility markers for CP and analyzed them in 2,914 PDAC cases, 356 CP cases and 5,596 controls retrospectively collected in the context of the international PANDoRA consortium. We found a weak association between the minor allele of the PRSS1-PRSS2-rs10273639 and an increased risk of developing PDAC (ORhomozygous = 1.19, 95% CI 1.02-1.38, p = 0.023). Additionally all the SNPs confirmed statistically significant associations with risk of developing CP, the strongest being PRSS1-PRSS2-rs10273639 (ORheterozygous = 0.51, 95% CI 0.39-0.67, p = 1.10 × 10-6 ) and MORC4-rs 12837024 (ORhomozygous = 2.07 (1.55-2.77, ptrend = 0.7 × 10-11 ). Taken together, the results from our study do not support variants rs11988997, rs379742, rs10273639, rs2995271 and rs12688220 as strong predictors of PDAC risk, but further support the role of these SNPs in CP susceptibility. Our study suggests that CP and PDAC probably do not share genetic susceptibility, at least in terms of high frequency variants.
Biomedical Center Faculty of Medicine in Pilsen Charles University Prague Pilsen Czech Republic
Department of Biology University of Pisa Pisa Italy
Department of Digestive Tract Diseases Medical University of Lodz Lodz Poland
Department of Epidemiology Nagoya University Graduate School of Medicine Nagoya Japan
Department of Gastroenterological Surgery Aichi Cancer Center Hospital Nagoya Japan
Department of Gastroenterology Aichi Cancer Center Hospital Nagoya Japan
Department of Gastroenterology Lithuanian University of Health Sciences Kaunas Lithuania
Department of General Surgery University Hospital Heidelberg Heidelberg Germany
Department of Laboratory Medicine University Hospital of Padova Padova Italy
Department of Medicine University of Padova Padova Italy
Department of Pathology Academic Medical Centre Amsterdam the Netherlands
Department of Surgery Academic Medical Centre Amsterdam the Netherlands
Department of Surgery Oncology and Gastroenterology University of Padova Padova Italy
Department of Surgery Pancreas Institute University and Hospital Trust of Verona Verona Italy
Department of Visceral Surgery Kantonsspital Aarau AG Aarau Switzerland
Digestive and Liver Disease Unit S Andrea Hospital 'Sapienza' University of Rome Rome Italy
Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany
Division of Clinical Epidemiology German Cancer Research Center Heidelberg Germany
Division of General and Transplant Surgery University of Pisa Pisa Italy
Division of Molecular and Clinical Epidemiology Aichi Cancer Center Research Institute Nagoya Japan
Division of Preventive Oncology German Cancer Research Center Heidelberg Germany
Genomic Epidemiology Group German Cancer Research Center Heidelberg Germany
German Cancer Consortium Heidelberg Germany
Transplant Surgery Department Institute for Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org